Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 2/20 | 0.39 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 6/20 | 0.38 |
| ▸ | ANPEP | P15144 | 5/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18009372 | 0.91 | PIK3CD (0.34) | PEPDXPNPEP1MMP2ANPEPPIK3CD | |
| SCHEMBL18009192 | 0.90 | PIK3CD (0.36) | PIK3CDHCAR2KEAP1NFE2L2AGTR2 | |
| SCHEMBL18009388 | 0.89 | PEPD (0.34) | PEPDXPNPEP1PIK3CDHCAR2KEAP1 | |
| SCHEMBL18009375 | 0.89 | PIK3CD (0.33) | PEPDXPNPEP1PIK3CDHCAR2KEAP1 | |
| SCHEMBL18007441 | 0.88 | PIN1 (0.35) | PEPDXPNPEP1PIK3CDHCAR2KEAP1 | |
| SCHEMBL18009295 | 0.86 | PIK3CD (0.34) | PIK3CDHCAR2KEAP1NFE2L2 | |
| SCHEMBL18009458 | 0.85 | MMP2 (0.54) | PEPDMMP2ANPEPHCAR2KEAP1 | |
| SCHEMBL18009287 | 0.84 | SLC6A3 (0.37) | MMP2ALDH1A1AGTR2 | |
| SCHEMBL18009223 | 0.83 | PIK3CD (0.32) | PIK3CD | |
| SCHEMBL18009358 | 0.83 | PIK3CD (0.32) | PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016127186-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-11 | — | — | WO | disclosed |